Continuous glucose monitoring can benefit patients with type 1 diabetes
BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j364 (Published 25 January 2017) Cite this as: BMJ 2017;356:j364- Jacqui Wise
- London
Continuous glucose monitoring can improve glycaemic control in patients with type 1 diabetes who use insulin injections, two studies published in JAMA have found.12
This consists of a sensor under the skin with a transmitter attached that reports glucose levels continuously to the patient on a handheld monitor. Most patients whose continuous glucose monitoring has been compared with self monitored blood glucose have used insulin pumps, whereas the two new studies were carried out in patients with type 1 diabetes who injected insulin.
The DIAMOND study included 158 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.